PHILIP MUSKIN: Open Payments
NPI 1508945650 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 10 payments from 5 companies in 2025. Trend: 2023 $479 · 2024 $908 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $233 |
| Teva Pharmaceuticals USA, Inc. | 2 | $197 |
| Axsome Therapeutics, Inc. | 1 | $150 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Bausch Health US, LLC | 4 | $98 |
Products named: CAPLYTA, Auvelity, FANAPT, UZEDY, APLENZIN, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
